{"id":"https://openalex.org/W2010394","doi":null,"title":"Rifampicin bioavailability: a review of its pharmacology and the chemotherapeutic necessity for ensuring optimal absorption.","display_name":"Rifampicin bioavailability: a review of its pharmacology and the chemotherapeutic necessity for ensuring optimal absorption.","publication_year":1999,"publication_date":"1999-11-01","ids":{"openalex":"https://openalex.org/W2010394","mag":"2010394","pmid":"https://pubmed.ncbi.nlm.nih.gov/10593709"},"language":"en","primary_location":{"id":"pmid:10593709","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10593709","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110159740","display_name":"Gordon A. Ellard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1310053265","display_name":"St George's Hospital","ror":"https://ror.org/0001ke483","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1310053265","https://openalex.org/I2801196673"]},{"id":"https://openalex.org/I165862685","display_name":"St George's, University of London","ror":"https://ror.org/040f08y74","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I165862685","https://openalex.org/I4401726869"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G A Ellard","raw_affiliation_strings":["Department of Medical Microbiology, St. George's Hospital Medical School, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Microbiology, St. George's Hospital Medical School, London, UK","institution_ids":["https://openalex.org/I1310053265","https://openalex.org/I165862685"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090582190","display_name":"Petrus Bernard Fourie","orcid":"https://orcid.org/0000-0002-1630-3554","observed_orcids":["https://orcid.org/0000-0002-1630-3554"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P B Fourie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.2117,"has_fulltext":false,"cited_by_count":42,"citation_normalized_percentile":{"value":0.7890236,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"3","issue":"11 Suppl 3","first_page":"S301","last_page":"8; discussion S317"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.6890000104904175,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.6890000104904175,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.13169999420642853,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.08160000294446945,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.9490000009536743},{"id":"https://openalex.org/keywords/fixed-dose-combination","display_name":"fixed-dose combination","score":0.8220000267028809},{"id":"https://openalex.org/keywords/tuberculosis-treatment","display_name":"tuberculosis treatment","score":0.7089999914169312},{"id":"https://openalex.org/keywords/isoniazid","display_name":"isoniazid","score":0.9089999794960022},{"id":"https://openalex.org/keywords/pyrazinamide","display_name":"pyrazinamide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ethambutol","display_name":"ethambutol","score":0.9120000004768372},{"id":"https://openalex.org/keywords/rifampicin-resistance","display_name":"rifampicin resistance","score":0.8410000205039978},{"id":"https://openalex.org/keywords/mycobacterium-tuberculosis","display_name":"Mycobacterium tuberculosis","score":0.8349999785423279},{"id":"https://openalex.org/keywords/drug-quality-evaluation","display_name":"drug quality assessment","score":0.45500001311302185},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.75}],"concepts":[{"id":"https://openalex.org/C2778607973","wikidata":"https://www.wikidata.org/wiki/Q422652","display_name":"Rifampicin","level":3,"score":0.9644824266433716},{"id":"https://openalex.org/C2780459521","wikidata":"https://www.wikidata.org/wiki/Q417571","display_name":"Pyrazinamide","level":4,"score":0.8509193658828735},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.770006537437439},{"id":"https://openalex.org/C2776967927","wikidata":"https://www.wikidata.org/wiki/Q423169","display_name":"Isoniazid","level":3,"score":0.7276641130447388},{"id":"https://openalex.org/C2776228421","wikidata":"https://www.wikidata.org/wiki/Q412318","display_name":"Ethambutol","level":4,"score":0.726668119430542},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.7021007537841797},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6778982877731323},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.5283967852592468},{"id":"https://openalex.org/C2777975735","wikidata":"https://www.wikidata.org/wiki/Q130971","display_name":"Mycobacterium tuberculosis","level":3,"score":0.43853509426116943},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.07125046849250793}],"mesh":[{"descriptor_ui":"D000042","descriptor_name":"Absorption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000904","descriptor_name":"Antibiotics, Antitubercular","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000904","descriptor_name":"Antibiotics, Antitubercular","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000995","descriptor_name":"Antitubercular Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014376","descriptor_name":"Tuberculosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:10593709","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10593709","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease","raw_type":"Journal Article"},{"id":"mag:2010394","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10593709","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2972645435","https://openalex.org/W2465230798","https://openalex.org/W7052412599","https://openalex.org/W2272729633","https://openalex.org/W2083241107","https://openalex.org/W1593227680","https://openalex.org/W1977933400","https://openalex.org/W1985603351","https://openalex.org/W2070069941","https://openalex.org/W2461259691"],"abstract_inverted_index":{"The":[0,29,119],"World":[1],"Health":[2],"Organization":[3],"encourages":[4],"the":[5,25,36,44,49,64,95,123,131,153,182],"use":[6,112],"of":[7,12,27,32,38,52,55,87,94,98,125,155,184,194],"fixed":[8],"dose":[9],"combinations":[10],"(FDCs)":[11],"rifampicin":[13,65,117,126,156],"(RMP)":[14],"and":[15,40,43,77,90,137,162,199],"isoniazid":[16,89],"together":[17,129],"with":[18,84,115,130],"pyrazinamide":[19,21],"or":[20,146],"plus":[22],"ethambutol":[23],"for":[24,134,166],"treatment":[26],"tuberculosis.":[28,57],"main":[30],"advantages":[31],"such":[33],"FDCs":[34,68,114,188],"are":[35],"simplification":[37],"procurement":[39],"prescribing":[41],"practices":[42],"protection":[45],"they":[46],"afford":[47],"against":[48],"potential":[50],"selection":[51],"RMP-resistant":[53],"strains":[54],"Mycobacterium":[56],"There":[58,174],"is":[59,104,127,171,175],"convincing":[60],"evidence,":[61],"however,":[62],"that":[63,107],"absorption":[66,154],"from":[67,157],"manufactured":[69],"under":[70],"suboptimal":[71],"conditions":[72],"may":[73],"be":[74,81],"significantly":[75],"impaired,":[76],"this":[78],"appears":[79],"to":[80,180],"especially":[82],"problematic":[83],"combined":[85,160],"formulations":[86,161],"rifampicin,":[88],"pyrazinamide.":[91],"In":[92],"view":[93],"marked":[96],"dose-dependence":[97],"rifampicin's":[99],"bacterial":[100],"sterilizing":[101],"action,":[102],"it":[103,136],"therefore":[105,176],"essential":[106],"tuberculosis":[108],"control":[109],"programmes":[110],"only":[111],"rifampicin-containing":[113,187],"proven":[116],"bioavailability.":[118],"comprehensive":[120],"literature":[121],"on":[122,163],"pharmacology":[124],"reviewed,":[128],"methods":[132,165],"employed":[133],"determining":[135],"its":[138],"most":[139],"important":[140],"metabolite,":[141],"desacetyl-rifampicin,":[142],"in":[143,189],"either":[144],"serum":[145],"urine.":[147],"By":[148],"contrast,":[149],"published":[150],"information":[151],"concerning":[152],"currently":[158,185],"marketed":[159,186],"laboratory":[164],"precisely":[167],"assessing":[168],"their":[169],"bioavailability":[170],"very":[172],"sparse.":[173],"a":[177],"crucial":[178],"need":[179],"establish":[181],"quality":[183],"studies":[190],"using":[191],"adequate":[192],"numbers":[193],"volunteers,":[195],"precise":[196],"analytical":[197],"techniques":[198],"sophisticated":[200],"statistical":[201],"techniques.":[202]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":7}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}